Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.
- 1 January 2002
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 20 (1), 95-99
- https://doi.org/10.1023/a:1014476602804
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.Journal of Clinical Oncology, 1998
- Evaluation of antitumour effects of docetaxel (Taxotere®) on human gastric cancers In vitro and In vivoEuropean Journal Of Cancer, 1996
- Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part IAnti-Cancer Drugs, 1995
- Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary.1994
- Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the EsophagusJNCI Journal of the National Cancer Institute, 1994
- Effects of taxotere on murine and human tumor cell linesBiochemical and Biophysical Research Communications, 1992
- Rising Incidence of Adenocarcinoma of the Esophagus and nGastric CardiaJAMA, 1991
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma.1983
- Phase II study of etoposide in the treatment of esophageal carcinoma.1983